July 17, 2026

Why Your Body Craves Progesterone and Peace

You fall asleep easily enough, but at 3am you're wide awake, mind racing, heart thumping, staring at the ceiling. Or perhaps you lie in bed for an hour before sleep finally comes, only to wake again drenched in sweat. Sound familiar?

If you are a woman in your 40s or early 50s, you are not alone, and you are not imagining it. Sleep disturbance affects between 40 and 60% of women during perimenopause and postmenopause, the transitional years leading up to the final menstrual period. For many women in Hong Kong, juggling demanding careers, family obligations, and the pressures of city life, disrupted sleep can feel like the final straw.

The good news: there are reasons why this is happening, and there is help available.

The Calming Hormone You Might Be Missing

Perimenopause typically begins in the mid-40s and can last four to ten years. During this time, the ovaries begin producing less oestrogen, and more importantly, less progesterone. While most people have heard of oestrogen, it is actually the decline in progesterone that often hits sleep first and hardest.

Here is why. In the brain, progesterone is converted into a neurosteroid called allopregnanolone, which binds to GABA receptors, the brain's natural "calm down" switches. GABA is the primary inhibitory neurotransmitter, and its activation is what allows the mind to quieten, anxiety to ease, and sleep to arrive naturally. When progesterone falls, this calming pathway weakens. The result is what many perimenopausal women describe as a distinctly anxious insomnia: waking at 3am with a racing mind and an inability to drift back off, even when nothing is wrong.

Declining oestrogen adds further disruption by destabilising the brain's thermoregulatory centre, triggering hot flushes and night sweats that jolt women out of deep sleep, sometimes multiple times a night. Together, these hormonal changes also reduce melatonin (the sleep hormone) and fragment the circadian rhythm.

Poor sleep in perimenopause is not trivial. Research now links chronic sleep disturbance at midlife to increased risk of cardiovascular disease, metabolic changes, mood disorders, and even cognitive decline in later years.

Natural Ways to Support Your Sleep Cycle

The foundation of managing perimenopausal sleep problems is lifestyle. These approaches have evidence behind them,  and many women are surprised by how much difference they can make.

1. Cognitive Behavioural Therapy for Insomnia (CBT-I)

CBT-I is consistently the most effective non-drug treatment for insomnia in perimenopausal women, more effective than sleeping tablets in the long term. It addresses the anxious thought patterns and unhelpful sleep behaviours that perpetuate waking. Group CBT programmes (including self-guided versions) have shown clinically meaningful improvements in sleep, hot flush bother, mood, and quality of life in 65–78% of women. NICE (UK) 2024 guidelines recommend CBT for managing menopausal symptoms.

2. Sleep Hygiene That Actually Works

 Keep a consistent sleep and wake time, even on weekends

• Keep the bedroom cool and well-ventilated (especially important for night sweats)

• Avoid screens for 30–60 minutes before bed; reduce blue light exposure

• Limit caffeine after midday and reduce alcohol, both fragment sleep architecture

• Reserve the bed for sleep only; avoid lying awake in bed for long periods

3. Regular Aerobic Exercise

Physical activity improves sleep quality and reduces the severity of vasomotor symptoms in menopausal women. Aim for at least 150 minutes of moderate-intensity exercise per week. Even brisk walking counts. The timing matters too, exercise earlier in the day tends to be more sleep-friendly than late evening workouts.

4. Diet and Nutrition

A balanced diet rich in protein, low-glycaemic carbohydrates, healthy fats, and omega-3 fatty acids supports both sleep quality and hormonal health. Reducing refined sugars and processed foods helps stabilise blood glucose and reduces the cortisol spikes that contribute to nocturnal waking. Phytoestrogen-rich foods (soy, tofu, edamame abundantly available in Hong Kong) may offer modest benefit for hot flush frequency in some women.

5. Stress Reduction and Mindfulness

Mindfulness-based stress reduction has been shown to reduce the bother of hot flushes and improve emotional wellbeing in perimenopausal women. In a city like Hong Kong, where stress is rarely in short supply, building a consistent practice, whether meditation, yoga, tai chi, or simply time outdoors, is one of the most underutilised tools for perimenopausal health.

When Lifestyle Is Not Enough: The Role of Hormone Replacement Therapy (HRT)

For many women, lifestyle measures provide meaningful relief. But for others, particularly those with frequent or severe symptoms, they are not sufficient on their own. This is where Menopausal Hormone Therapy (MHT, also called HRT) becomes an important conversation.

HRT is the most effective treatment for vasomotor symptoms, and evidence supports its use in healthy women under 60 who are within 10 years of the start of their menopausal transition. But beyond hot flushes, HRT can improve sleep through multiple pathways, both by reducing night sweats and by directly acting on the brain's sleep-wake systems.

The progesterone piece is particularly important. Oral micronised progesterone (the bioidentical form of the body's own progesterone) has a well-established sleep-promoting effect via GABA receptor activation. Taken at bedtime, it increases deep (non-REM) sleep and reduces nocturnal awakenings. A systematic review and meta-analysis of randomised controlled trials found that micronised progesterone improved sleep onset latency and self-reported sleep quality across multiple studies, and importantly, these benefits were observed even independently of its effect on night sweats and hot flushes. Unlike sleeping tablets, it carries no risk of addiction or suppression of normal breathing during sleep.

Current evidence supports transdermal oestradiol (patch or gel) combined with oral micronised progesterone (for women with a uterus) as a preferred regimen, given its favourable safety and tolerability profile.

HRT is not right for every woman, and the decision involves a personalised assessment of symptoms, health history, risk factors, and preferences. The conversation is worth having, and many women are pleasantly surprised to find that the risk-benefit picture has shifted considerably from what was reported two decades ago.

You Do Not Have to Navigate This Alone

Perimenopause is a normal life transition, but one that can significantly affect quality of life, work performance, relationships, and long-term health if left unaddressed.

If you are lying awake at 3am wondering why your body feels like a stranger to you, speak to your doctor. A GP can help you work through your options from lifestyle and sleep strategies, to a thorough and individualised conversation about whether hormone therapy is right for you.

Good sleep is not a luxury. It is the foundation of everything.

References

1. Baker, F.C., de Zambotti, M., Colrain, I.M. and Bei, B. (2018) 'Sleep problems during the menopausal transition: prevalence, impact, and management challenges', Nature and Science of Sleep, 10, pp. 73–95. doi: 10.2147/NSS.S125807. Available at: https://pubmed.ncbi.nlm.nih.gov/29445307 (Accessed: 7 July 2026).
2. Ciano, C., King, T.S., Wright, R.R., Perlis, M. and Sawyer, A.M. (2017) 'Longitudinal study of insomnia symptoms among women during perimenopause', Journal of Obstetric, Gynecologic and Neonatal Nursing, 46(6), pp. 804–813. doi: 10.1016/j.jogn.2017.07.011. Available at: https://pubmed.ncbi.nlm.nih.gov/28886339 (Accessed: 7 July 2026).
3. Drake, C.L., Kalmbach, D.A., Arnedt, J.T. et al. (2019) 'Treating chronic insomnia in postmenopausal women: a randomized clinical trial comparing cognitive-behavioral therapy for insomnia, sleep restriction therapy, and sleep hygiene education', Sleep, 42(2), zsy217. doi: 10.1093/sleep/zsy217. Available at: https://pubmed.ncbi.nlm.nih.gov/30481333 (Accessed: 7 July 2026).
4. Kravitz, H.M. and Joffe, H. (2011) 'Sleep during the perimenopause: a SWAN story', Obstetrics and Gynecology Clinics of North America, 38(3), pp. 567–586. doi: 10.1016/j.ogc.2011.06.002. Available at: https://pubmed.ncbi.nlm.nih.gov/21961720 (Accessed: 7 July 2026).
5. McCurry, S.M., Guthrie, K.A., Morin, C.M. et al. (2016) 'Telephone-based cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women with vasomotor symptoms: a MsFLASH randomized clinical trial', JAMA Internal Medicine, 176(7), pp. 913–920. doi: 10.1001/jamainternmed.2016.1795. Available at: https://pubmed.ncbi.nlm.nih.gov/27213646 (Accessed: 7 July 2026).
6. Memi, E., Pavli, P., Papagianni, M., Vrachnis, N. and Mastorakos, G. (2024) 'Diagnostic and therapeutic use of oral micronized progesterone in endocrinology', Reviews in Endocrine and Metabolic Disorders, 25, pp. 751–772. doi: 10.1007/s11154-024-09882-0. Available at: https://pubmed.ncbi.nlm.nih.gov/38652231 (Accessed: 7 July 2026).
7. Nolan, B.J., Liang, B. and Cheung, A.S. (2021) 'Efficacy of micronized progesterone for sleep: a systematic review and meta-analysis of randomized controlled trial data', Journal of Clinical Endocrinology and Metabolism, 106(4), pp. 942–951. doi: 10.1210/clinem/dgaa873. Available at: https://pubmed.ncbi.nlm.nih.gov/33245776 (Accessed: 7 July 2026).
8. Prior, J.C. and Vitzthum, V.J. (2026) 'Progesterone for reproductive vitality and women's healthy ageing', Exploration of Endocrine and Metabolic Diseases, 3, 101460. Available at: https://doi.org/10.37349/eemd.2024.101460 (Accessed: 7 July 2026).
9. Zeng, W., Xu, J., Yang, Y., Lv, M. and Chu, X. (2025) 'Factors influencing sleep disorders in perimenopausal women: a systematic review and meta-analysis', Frontiers in Neurology, 16, 1460613. doi: 10.3389/fneur.2025.1460613. Available at: https://pubmed.ncbi.nlm.nih.gov/39990264 (Accessed: 7 July 2026).
10. van Driel, C.M., Stuursma, A., Schroevers, M.J., Mourits, M.J. and de Bock, G.H. (2019) 'Mindfulness, cognitive behavioural and behaviour-based therapy for natural and treatment-induced menopausal symptoms: a systematic review and meta-analysis', BJOG: An International Journal of Obstetrics and Gynaecology, 126(3), pp. 330–339. doi: 10.1111/1471-0528.15153. Available at: https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.15153 (Accessed: 7 July 2026).